Evidence map›Paper›PMID 24820035›Full record

ArticleEMBO reports2014

DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1-mediated transcriptional repression.

Suk Min Jang, Saliha Azebi, Guillaume Soubigou, Christian Muchardt

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. DYRK1A roles in human neural progenitors.Frontiers in neuroscience · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. The Omnipresence of DYRK1A in Human Diseases.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Genes · 2021
    Review
  13. Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorder.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Suk Min JangInstitut Pasteur, Dpt Biologie du Développement et Cellules Souches Unité de Régulation Epigénétique, Paris, France URA2578, CNRS, Paris, France Sorbonne Universités UPMC Univ Paris06, IFD, Paris cedex05, France.
Saliha AzebiInstitut Pasteur, Dpt Biologie du Développement et Cellules Souches Unité de Régulation Epigénétique, Paris, France URA2578, CNRS, Paris, France Sorbonne Universités UPMC Univ Paris06, IFD, Paris cedex05, France.
Guillaume SoubigouInstitut Pasteur, Dpt Génomes et Génétique, Plate-forme Transcriptome et Epigénome, Paris, France.
Christian MuchardtInstitut Pasteur, Dpt Biologie du Développement et Cellules Souches Unité de Régulation Epigénétique, Paris, France URA2578, CNRS, Paris, France christian.muchardt@pasteur.fr.
Biologie du Développement et Cellules SouchesCentre National de la Recherche Scientifique · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterochromatin protein 1 (HP1) proteins are chromatin-bound transcriptional regulators. While their chromodomain binds histone H3 methylated on lysine 9, their chromoshadow domain associates with the H3 histone fold in a region involved in chromatin remodeling. Here, we show that phosphorylation at histone H3 threonine 45 and serine 57 within this latter region differentially affects binding of the three mammalian HP1 isoforms HP1α, HP1β and HP1γ. Both phosphorylation events are dependent on the activity of the DYRK1A kinase that antagonizes HP1-mediated transcriptional repression and participates in abnormal activation of cytokine genes in Down's syndrome-associated megakaryoblastic leukemia.

Indexed as

Blotting, WesternCell Line, TumorChromatin ImmunoprecipitationChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneDyrk KinasesExonsGene Expression RegulationHistonesHumansImmunoblottingOligonucleotide Array Sequence AnalysisPhosphorylationPromoter Regions, GeneticProtein BindingProtein IsoformsCBX1 protein, humanCBX5 protein, humanChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneDyrk KinasesHistonesProtein IsoformsProtein Serine-Threonine KinasesProtein-Tyrosine Kinaseschromatin silencingcytokineepigenetichistone codeinflammation

Identifiers

PMID24820035
PMCPMC4197879
OpenAlexW2141406151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.